Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
EQUITY AND LIABILITIES
No of Months
12
12
12
12
Share Capital
24.69
24.68
24.61
23.82
Share Warrants & Outstandings
Total Reserve
1,836.92
1,674.51
1,398.83
238.47
Shareholder's Funds
1,864.01
1,701.55
1,431.02
262.29
Minority Interest
0.00
0.01
0.00
0.00
Long-Term Borrowings
151.60
59.36
0.79
842.83
Secured Loans
151.60
59.36
0.79
842.83
Unsecured Loans
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
118.85
122.66
115.15
9.56
Other Long Term Liabilities
42.19
31.23
35.71
240.71
Long Term Trade Payables
0.00
0.00
0.00
0.00
Long Term Provisions
15.10
5.07
0.05
0.34
Total Non-Current Liabilities
327.74
218.31
151.69
1,093.44
Current Liabilities
Trade Payables
105.05
99.81
95.56
112.29
Other Current Liabilities
64.75
34.23
55.90
60.42
Short Term Borrowings
26.46
0.19
20.70
2.05
Short Term Provisions
1.01
0.64
0.26
0.82
Total Current Liabilities
197.28
134.87
172.41
175.59
Total Liabilities
2,389.03
2,054.74
1,755.13
1,531.31
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
Gross Block
1,746.58
1,510.36
1,394.12
1,314.79
Less: Accumulated Depreciation
461.05
392.22
329.06
269.15
Less : Impairment of Assets
0.00
0.00
0.00
0.00
Net Block
1,285.52
1,118.14
1,065.06
1,045.64
Lease Adjustment
0.00
0.00
0.00
0.00
Capital Work in Progress
64.83
46.18
36.18
17.20
Intangible assets under development
4.50
2.00
0.00
0.04
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
Non Current Investments
136.50
0.00
0.00
0.09
Long Term Loans & Advances
100.47
108.29
11.79
29.15
Other Non Current Assets
13.28
12.40
20.35
0.00
Total Non-Current Assets
1,697.64
1,328.58
1,178.41
1,132.66
Current Assets Loans & Advances
Current Investments
202.17
349.87
210.08
11.12
Inventories
168.13
127.29
167.76
120.79
Sundry Debtors
164.57
156.38
117.74
152.97
Cash and Bank
52.84
45.48
32.67
58.70
Other Current Assets
10.10
5.25
9.15
15.15
Short Term Loans and Advances
93.58
41.89
39.31
39.92
Total Current Assets
691.39
726.16
576.72
398.65
Net Current Assets (Including Current Investments)
494.11
591.29
404.31
223.06
Total Current Assets Excluding Current Investments
489.22
376.29
366.64
387.53
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
Total Assets
2,389.03
2,054.74
1,755.13
1,531.31
Contingent Liabilities
57.84
58.36
13.09
17.05
Total Debt
0.00
59.54
21.49
844.88
Book Value per share (adjusted)
151.02
137.89
116.29
26.75
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 199.06% vs 177.06% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 35.09% vs -12.55% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is 15.98% vs 5.73% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is -4.79% vs 25.91% in Mar 2024
Compare Balance Sheet Results of Archean Chemical
Figures in Cr
Consolidated - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
24.69
43.14
-18.45
-42.77%
Share Warrants & Outstandings
Total Reserve
1,836.92
1,861.39
-24.47
-1.31%
Shareholder's Funds
1,864.01
1,904.53
-40.52
-2.13%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
151.60
448.97
-297.37
-66.23%
Secured Loans
151.60
448.97
-297.37
-66.23%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
118.85
293.65
-174.80
-59.53%
Other Long Term Liabilities
42.19
6.75
35.44
525.04%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
15.10
5.80
9.30
160.34%
Total Non-Current Liabilities
327.74
755.17
-427.43
-56.60%
Current Liabilities
Trade Payables
105.05
185.68
-80.63
-43.42%
Other Current Liabilities
64.75
171.13
-106.38
-62.16%
Short Term Borrowings
26.46
135.61
-109.15
-80.49%
Short Term Provisions
1.01
0.32
0.69
215.62%
Total Current Liabilities
197.28
492.74
-295.46
-59.96%
Total Liabilities
2,389.03
3,152.44
-763.41
-24.22%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
1,746.58
2,953.09
-1,206.51
-40.86%
Less: Accumulated Depreciation
461.05
715.07
-254.02
-35.52%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
1,285.52
2,238.02
-952.50
-42.56%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
64.83
63.89
0.94
1.47%
Intangible assets under development
4.50
0.00
4.50
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
136.50
21.54
114.96
533.70%
Long Term Loans & Advances
100.47
53.72
46.75
87.03%
Other Non Current Assets
13.28
0.03
13.25
44,166.67%
Total Non-Current Assets
1,697.64
2,377.20
-679.56
-28.59%
Current Assets Loans & Advances
Current Investments
202.17
76.60
125.57
163.93%
Inventories
168.13
387.99
-219.86
-56.67%
Sundry Debtors
164.57
232.32
-67.75
-29.16%
Cash and Bank
52.84
22.19
30.65
138.13%
Other Current Assets
10.10
40.23
-30.13
-74.89%
Short Term Loans and Advances
93.58
15.91
77.67
488.18%
Total Current Assets
691.39
775.24
-83.85
-10.82%
Net Current Assets (Including Current Investments)
494.11
282.50
211.61
74.91%
Total Current Assets Excluding Current Investments
489.22
698.64
-209.42
-29.98%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
2,389.03
3,152.44
-763.41
-24.22%
Contingent Liabilities
57.84
67.32
-9.48
-14.08%
Total Debt
0.00
584.58
-584.58
-100.00%
Book Value per share (adjusted)
151.02
441.48
-290.46
-65.79%
Annual - Borrowings
Borrowings 178.06 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 199.06% vs 177.06% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 42.19 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 35.09% vs -12.55% in Mar 2024
Annual - Fixed Assets
Fixed Assets 1,350.35 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 15.98% vs 5.73% in Mar 2024
Annual - Investments
Investments 136.50 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 691.39 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -4.79% vs 25.91% in Mar 2024






